Indefinite Delivery Contract 75N91023D00008
Award Date
4/11/23
Last Date to Order
4/10/28
Federal Agency
National Cancer Institute
Awardee
Research Triangle Institute
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
B504 - Special Studies/Analysis- Chemical/Biological
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The multiple award IDV was issued by the National Cancer Institute, within the Department of Health and Human Services' National Institutes of Health, to provide analysis and synthesis of GMP and non-GMP bulk drugs and pharmaceutical formulations. Mriglobal, doing business as Midwest Research Institute, was awarded the IDV with a potential value of $12.1M and a period of performance through April 2028. The IDV facilitates the placement of task orders for preclinical and clinical development...
This indefinite delivery contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to provide Biomedical Information Management and Analytic Support Services. The multiple award IDV has a potential value of $148 million over five years. Task orders issued to date include $1.56 million for data analytics, statistical analysis and bioinformatics support for genome-wide association studies under cost plus fixed fee pricing to...
The contract IDV award is for the PREVENT Cancer Preclinical Drug Development Program, a multiple-award IDIQ contract administered by the National Cancer Institute (NCI). The program encompasses three main technical areas: (1) evaluation of the efficacy and pharmacodynamic/efficacy biomarkers for potential cancer preventive agents, (2) preclinical product development, analytical testing, process development, and cGMP manufacturing support for cancer preventive vaccines, and (3) pharmacological...
This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to IIT Research Institute (IITRI), a non-profit contract research organization. The contract, with a ceiling value of $0, is part of the Preclinical Agent Development Assays 2012-2016 program and supports preclinical in vitro and in vivo agent development assays. Under this IDC, IITRI provides a range of preclinical research...
This indefinite delivery contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Sri International, a non-profit research and development organization. The contract, with a ceiling value of $9,900,000, has an ultimate completion date of September 26, 2028. The purpose of this IDC is to obtain research and development services to support preclinical pharmacokinetic and pharmacology evaluations of agents being...
The National Cancer Institute (NCI) awarded a multiple-award Indefinite Delivery Contract (IDC) with a $149,995,000 ceiling value to The Institute For Cancer Research, a non-profit organization and subsidiary of Temple University, to provide preclinical efficacy and biomarker analysis services in support of the PREVENT Cancer Preclinical Drug Development Program. This 5-year IDC contract includes three technical pools: Preclinical Efficacy and Biomarkers, Preclinical Services for Product...
This indefinite delivery contract (IDC) was awarded by a U.S. federal government agency to IIT Research Institute (IITRI), a non-profit contract research organization. The IDC is a multiple-award vehicle with a $0 ceiling value and an ultimate completion date of September 30, 2007. Under this IDC, IITRI provides a range of preclinical research services to support federal agencies such as the National Institutes of Health (NIH), including the National Cancer Institute (NCI), National Institute of...
The National Institutes of Health National Cancer Institute awarded an indefinite delivery/indefinite quantity multiple award contract to provide support services for cancer clinical trials. Under the master contract, Technical Resources International was issued delivery orders valued at $5.56 million to provide project kickoff meeting support and centralized protocol writing support. Performance will take place in Westlake, Maryland through July 2027. The original solicitation sought to...
The key products and services being delivered under this federal contract IDV award from the National Cancer Institute (NCI) are preclinical toxicology studies on small molecule drug candidates for cancer and other indications. The prime contractor, IIT Research Institute (IITRI), a division of the Illinois Institute of Technology, will conduct non-GLP and GLP toxicology assessments in mice and dogs to support Investigational New Drug (IND) applications. IITRI holds several significant IDIQ...
The federal contract IDV is an Indefinite Delivery Contract (IDC) awarded by the National Cancer Institute (NCI), which is part of the Department of Health and Human Services (HHS) and the National Institutes of Health (NIH). The prime contractor is the Public Health Institute (PHI), a non-profit organization. The IDC, valued at $275,000,000, is for the Surveillance, Epidemiology, and End Results (SEER) program, which conducts cancer epidemiology research and surveillance. Under this IDC, PHI...